The Trump administration has partnered with the pharmaceutical company MediWound to develop a treatment for injuries caused by mustard gas, which was first used in World War I but officials worry could be used by terrorists.
The Department of Health and Human Services announced the $43 million partnership with the Israeli company to develop a skin treatment for injuries on Monday. Currently, there are no treatments available for mustard gas approved by the Food and Drug Administration.
Real journalism.Trusted by millions.
Unlimited access to in-depth reporting, expert analysis, and the stories that shape our country.
Subscribe Now
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.